Showing results (201-210 of 302) with videos related to

Sort By:
Pageof 31
Leukemia|October 19, 2007
Release of angiopoietin-1 by primary human acute myelogenous leukemia cells is associated with mutations of nucleophosmin, increased by bone marrow stromal cells and possibly antagonized by high systemic angiopoietin-2 levelsK J Hatfield, R Hovland, A M Øyan, et al.
Autoimmunity|January 1, 1996
Linomide increases plasma corticosterone in normal rats, but does not prevent the inhibitory action of IL-1 on beta-cells in vivo or ex vivoU B Christensen, D Mauricio, J I Reimers, et al.
The Journal of Biological Chemistry|November 15, 1993
Isolation, partial characterization, and molecular cloning of a human colon adenocarcinoma cell-surface glycoprotein recognized by the C215 mouse monoclonal antibodyP Björk, U Jönsson, H Svedberg, et al.
Cytometry. Part B, Clinical Cytometry|January 26, 2005
CD34 expression in native human acute myelogenous leukemia blasts: differences in CD34 membrane molecule expression are associated with different gene expression profilesAnne Margrete Oyan, Trond Hellem Bø, Inge Jonassen, et al.
Melanoma Research|June 1, 1997
Superantigen-induced lysis of melanoma cellsF Krull, U Holzer, J Ihle, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 18, 1997
Genetically engineered superantigens as tolerable antitumor agentsJ Hansson, L Ohlsson, R Persson, et al.
Acta Neurologica Scandinavica|January 1, 1994
Absence of HTLV-1 related sequences in MS from high prevalence areas in western NorwayK M Myhr, P Frost, M Grønning, et al.
Journal of Neuroimmunology|April 1, 1997
Immunomodulation of autoimmunity by linomide: inhibition of antigen presentation through down regulation of macrophage activity in the model of experimental autoimmune encephalomyelitisD Lehmann, D M Karussis, D Fluresco, et al.
Frontiers in Pharmacology|August 29, 2022
Licensing of Orphan Medicinal Products-Use of Real-World Data and Other External Data on Efficacy Aspects in Marketing Authorization Applications Concluded at the European Medicines Agency Between 2019 and 2021Frauke Naumann-Winter, Franziska Wolter, Ulrike Hermes, et al.
Critical Care Explorations|April 4, 2022
Outcomes of Patients Undergoing Interfacility Extracorporeal Membrane Oxygenation Transfer Based on Cannulation Location and Mode of TransportJillian K Wothe, Zachary R Bergman, Krystina R Kalland, et al.
Pageof 31